4.15
Ispecimen Inc stock is traded at $4.15, with a volume of 109.71K.
It is up +4.53% in the last 24 hours and down -7.20% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
See More
Previous Close:
$3.97
Open:
$3.98
24h Volume:
109.71K
Relative Volume:
0.13
Market Cap:
$5.46M
Revenue:
$1.93M
Net Income/Loss:
$-10.49M
P/E Ratio:
-0.0472
EPS:
-87.9728
Net Cash Flow:
$-5.24M
1W Performance:
-18.95%
1M Performance:
-7.20%
6M Performance:
-83.47%
1Y Performance:
-91.13%
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, IDXX, WAT, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ISPC
Ispecimen Inc
|
4.15 | 5.22M | 1.93M | -10.49M | -5.24M | -87.97 |
|
TMO
Thermo Fisher Scientific Inc
|
438.34 | 166.56B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
161.91 | 116.46B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
528.79 | 42.03B | 4.45B | 1.10B | 1.06B | 13.59 |
|
WAT
Waters Corp
|
329.22 | 32.72B | 3.77B | 449.25M | 240.68M | 7.8556 |
|
A
Agilent Technologies Inc
|
111.70 | 32.01B | 7.07B | 1.29B | 993.00M | 4.5355 |
Ispecimen Inc Stock (ISPC) Latest News
ISPC Should I Buy - Intellectia AI
iSpecimen stock (US46536T1016): capital raise and Nasdaq compliance in focus - AD HOC NEWS
iSpecimen Inc. Announces $2.5 Million Private Placement to Support Marketplace Growth and Marketing Efforts - Minichart
iSpecimen Regains Nasdaq Compliance and Raises New Capital - TipRanks
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
iSpecimen (Nasdaq: ISPC) prices $2.5M private placement and regains Nasdaq bid compliance - Stock Titan
iSpecimen raises $2.5M in private placement via E.F. Hutton - Investing.com
iSpecimen raises $2.5M in private placement via E.F. Hutton By Investing.com - Investing.com Australia
MSN Money - MSN
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement - marketscreener.com
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement - GlobeNewswire Inc.
E.F. Hutton Secures $2.5 Million for iSpecimen - Intellectia AI
TradingKey - TradingKey
iSpecimen announces pricing of approximately $2.5M private placement - MSN
ISpecimen Inc. announced that it has received $2.500004 million in funding - marketscreener.com
iSpecimen prices $2.5M private placement at $5.12 per share By Investing.com - Investing.com Australia
iSpecimen Completes $2.5 Million Private Placement - Intellectia AI
ISPCiSpecimen Inc. stock news, filings & ratings - Quantisnow
In $2.5M financing, iSpecimen earmarks up to $900,000 for marketing - Stock Titan
iSpecimen Announces $2.5 Million Private Placement Priced at $1.10 Per Share - geneonline.com
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement - Scott Coop
iSpecimen prices $2.5M private placement at $5.12 per share - Investing.com
ISpecimen Inc. announced that it expects to receive $2.499999 million in funding - marketscreener.com
iSpecimen Inc (ISPC) - MSN
iSpecimen Company Profile & Introduction - Moomoo
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):